TGFB1 and cancer: Similarly, preclinical data support synergistic effects with the combination of bintrafusp alfa and chemotherapy because TGF‐β inhibition may normalize the extracellular matrix and improve drug delivery and resistance through effects on fibrosis, EMT, and angiogenesis and elimination of chemotherapy‐resistant cancer stem‐like cells [88, 100].